Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study.
Lombardi G, Barresi V, Indraccolo S, Simbolo M, Fassan M, Mandruzzato S, Simonelli M, Caccese M, Pizzi M, Fassina A, Padovan M, Masetto E, Gardiman MP, Bonavina MG, Caffo M, Persico P, Chioffi F, Denaro L, Dei Tos AP, Scarpa A, Zagonel V.
Lombardi G, et al. Among authors: mandruzzato s.
Cancers (Basel). 2020 Aug 14;12(8):2283. doi: 10.3390/cancers12082283.
Cancers (Basel). 2020.
PMID: 32823925
Free PMC article.